MedPath logo

CRAVIT OPHTHALMIC SOLUTION 0.5% w/v

Prescription Only
Drug type: Therapeutic
ATC code: S01AX19
Dosage form: SOLUTION
Route of administration: OPHTHALMIC
Active ingredient: LEVOFLOXACIN HYDRATE; LEVOFLOXACIN HYDRATE

[Indications]

The following infections caused by levofloxacin-susceptible strains of Staphylococcus sp., Streptococcus sp., Streptococcus pneumoniae, Micrococcus sp., Enterococcus sp., Corynebacterium sp., Pseudomonas sp., Pseudomonas aeruginosa, Haemophilus sp. ( H. influenzae, H. aegyptius [ Koch-Weeks bacillus]), Moraxella ( Branhamella) catarrhalis, Moraxella sp. ( Morax-Axenfeld bacillus), Serratia sp., Klebsiella sp., Proteus sp., Acinetobacter sp., Enterobacter sp,. Propionibacterium acnes :

Blepharitis, hordeolum, dacryocystitis, conjunctivitis, tarsadenitis, keratitis, corneal ulcer, and postoperative infections.

[Contraindications] (Cravit ophthalmic solution is contraindicated in the following patients.)

Patients with a history of hypersensitivity to the ingredient of this product, Ofloxacin or any quinolone antibiotics.

[Dosage and Administration]

Usually, instill 1 drop a time 3 times daily. The dosage may be adjusted according to the patient's symptoms.

Registrant
SANTEN PHARMACEUTICAL ASIA PTE. LTD.
Approval Date
2002-02-28
Approval Number
SIN11826P
Manufacturer
Santen Pharmaceutical Co., Ltd (Noto Plant)
Licence Holder
SANTEN PHARMACEUTICAL ASIA PTE. LTD.